Fatty acid composition of PMBC - before and after 2 mo of interventions and after 2 mo of follow-up [clinicaltrials_resource:147711933b323920e4600eadb19a42e4]

Fatty acid composition of PMBC - before and after 2 mo of interventions and after 2 mo of follow-up [clinicaltrials_resource:147711933b323920e4600eadb19a42e4]

clinicaltrials resource [clinicaltrials_vocabulary:Resource]
Secondary outcome [clinicaltrials_vocabulary:secondary-outcome]
http://bio2rdf.org/clinicaltrials_resource:147711933b323920e4600eadb19a42e4
The Effect of n-3 LCPUFA on Immune Function and Cardiovascular Risk Factors [clinicaltrials:NCT00266292]
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]

Fatty acid composition of PMBC - before and after 2 mo of interventions and after 2 mo of follow-up [clinicaltrials_resource:147711933b323920e4600eadb19a42e4]

clinicaltrials resource [clinicaltrials_vocabulary:Resource]
Secondary outcome [clinicaltrials_vocabulary:secondary-outcome]
http://bio2rdf.org/clinicaltrials_resource:147711933b323920e4600eadb19a42e4
Bio2RDF identifier
147711933b323920e4600eadb19a42e4
Bio2RDF namespace
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:147711933b323920e4600eadb19a42e4
measure [clinicaltrials_vocabulary:measure]
Fatty acid composition of PMBC ...... ns and after 2 mo of follow-up
identifier
clinicaltrials_resource:147711933b323920e4600eadb19a42e4
title
Fatty acid composition of PMBC ...... ns and after 2 mo of follow-up
@en
inDataset
type
label
Fatty acid composition of PMBC ...... 711933b323920e4600eadb19a42e4]
@en